SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
  • 2
    Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003; 98: 632-644.
  • 3
    Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer. 2012; 118: 3153-3164.
  • 4
    Jerjes W, Upile T, Radhi H, et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication. Head Neck Oncol. 2012; 4: 6.
  • 5
    Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010; 340: b5569.
  • 6
    Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; 78: 409-412.
  • 7
    Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003; 14: 131-138.
  • 8
    Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; 328: 159-163.
  • 9
    Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009; 40: 135-146.
  • 10
    Zevallos JP, Mallen MJ, Lam CY, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; 115: 4636-4644.
  • 11
    Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004; 164: 2206-2216.
  • 12
    Møller AM, Pedersen T, Villebro N, Schnaberich A, Haas M, Tønnesen R. A study of the impact of long-term tobacco smoking on postoperative intensive care admission. Anaesthesia. 2003; 58: 55-59.
  • 13
    Smith JB, Fenske NA. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol. 1996; 34: 717-732.
  • 14
    Gritz ER. Smoking and smoking cessation in cancer patients. Br J Addict. 1991; 86: 549-554.
  • 15
    Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999; 21: 420-427.
  • 16
    Duffy SA, Terrell JE, Valenstein M, Ronis DL, Copeland LA, Connors M. Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry. 2002; 24: 140-147.
  • 17
    Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004; 126: 1733-1741.
  • 18
    Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991; 2: 105-112.
  • 19
    Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995; 75: 569-576.
  • 20
    Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997; 107: 888-892.
  • 21
    Browning KK, Ahijevych KL, Ross P Jr, Wewers ME. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncol Nurs Forum. 2000; 27: 1248-1254.
  • 22
    Wewers ME, Bowen JM, Stanislaw AE, Desimone VB. A nurse-delivered smoking cessation intervention among hospitalized postoperative patients—influence of a smoking-related diagnosis: a pilot study. Heart Lung. 1994; 23: 151-156.
  • 23
    Nayan S, Gupta MK, Sommer DD. Evaluating smoking cessation interventions and cessation rates in cancer patients: a systematic review and meta-analysis. ISRN Oncol. 2011;2 011: 849023.
  • 24
    Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2203-2208.
  • 25
    Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; 110: 1199-1202.
  • 26
    Davison AG, Duffy M. Smoking habits of long-term survivors of surgery for lung cancer. Thorax. 1982; 37: 331-333.
  • 27
    Walker MS, Larsen RJ, Zona DM, Govindan R, Fisher EB. Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study. Prev Med. 2004; 39: 449-457.
  • 28
    Schnoll RA, James C, Malstrom M, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003; 25: 214-222.
  • 29
    Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2370-2377.
  • 30
    Witkiewitz K, Marlatt GA. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol. 2004; 59: 224-235.
  • 31
    Simmons VN, Litvin EB, Patel RD, et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns. 2009; 77: 398-403.
  • 32
    Simmons VN, Litvin EB, Unrod M, Brandon TH. Oncology healthcare providers' implementation of the 5A's model of brief intervention for smoking cessation: patients' perceptions. Patient Educ Couns. 2012; 86: 414-419.
  • 33
    Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86: 1119-1127.
  • 34
    Hall SM, Havassy BE, Wasserman DA. Effects of commitment to abstinence, positive moods, stress, and coping on relapse to cocaine use. J Consult Clin Psychol. 1991; 59: 526-532.
  • 35
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.
  • 36
    Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress. Cancer. 1997; 80: 1936-1944.
  • 37
    Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41: 209-218.
  • 38
    Henderson JW, Donatelle RJ, Acock AC. Confirmatory factor analysis of the cancer locus of control scale. Educ Psychol Meas. 2002; 62: 995-1005.
  • 39
    Cleeland CS. Measurement of pain by subjective report. In: Chapman CR, Loeser JD, editors. Advances in Pain Research and Therapy. Volume 12: Issues in Pain Measurement. New York, NY: Raven Press; 1989: 391-403.
  • 40
    Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85: 1186-1196.
  • 41
    Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004; 99: 29-38.
  • 42
    Cooley ME, Emmons KM, Haddad R, et al. Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer. 2011; 117: 2961-2969.
  • 43
    Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull. 2003; 129: 270-304.
  • 44
    Brandon TH, Unrod M. Tobacco use and cessation. In: Holland JC, Breitbart W, Jacobsen PB, Lederberg MS, McCorkle R, editors. Psycho-oncology. 2nd edition. New York, NY: Oxford University Press; 2010.
  • 45
    Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2287-2293.
  • 46
    McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003; 10: 325-333.